Province Expands the Use of Biosimilars to Improve the Sustainability of Public Drug Plans
Shots:
- The provincial government is improving the sustainability of its public drug plans by expanding the use of biosimilars
- This initiative follows similar policies implemented by British Columbia and Alberta over the past 2yrs.- where 10-000 of patients in each province were safely switched from an originator biologic drug to a biosimilar
- The initiative allows the government to fund new drugs as switching to biosimilar results in savings. The province’s plans to provide subsidized drug coverage for about 135-000 people while in 2019-20- the province invested about $220M in these drug plans
Ref: Biosimilars | Image: Twitter
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com